Stock 4120 ORIENT EUROPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
42.2 TWD +2.30% Intraday chart for Orient EuroPharma Co., Ltd. +3.43% +8.48%
Apr. 05 Regeneus Ltd announced that it expects to receive AUD 3.481164 million in funding from Zheng Yang Biomedical Technology Co., Ltd., Orient EuroPharma Co., Ltd. and other investors CI
Mar. 29 Orient EuroPharma Co., Ltd. announced that it expects to receive TWD 300 million in funding CI

Business Summary

Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Western Pharma BU
52.8 %
2,327 49.2 % 2,426 52.8 % +4.23%
Nutricare BU
47.2 %
2,403 50.8 % 2,166 47.2 % -9.86%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
62.8 %
2,785 58.9 % 2,885 62.8 % +3.57%
Southeast Asia
21.6 %
910 19.2 % 993 21.6 % +9.13%
China
15.3 %
1,035 21.9 % 702 15.3 % -32.24%
Others
0.3 %
0 0.0 % 13 0.3 % -

Managers

Managers TitleAgeSince
Cheng Hung Tsai CHM
 Chairman - -
Anita Chen IRC
 Investor Relations Contact - -
I Hsin Chang AUD
 Comptroller/Controller/Auditor - 20-12-31

Members of the board

Members of the board TitleAgeSince
Praveen Tyle BRD
 Director/Board Member 64 02-12-31
Cheng Hung Tsai CHM
 Chairman - -
Hwa-Min Lin BRD
 Director/Board Member - 22-06-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 86,747,100 30,509,119 ( 35.17 %) 0 35.17 %

Shareholders

NameEquities%Valuation
Dimensional Fund Advisors Ltd.
0.0100 %
8,677 0.0100 % 11 794 NT$
DFA Australia Ltd.
0.001991 %
1,727 0.001991 % 2 347 NT$

Company contact information

Orient Europharma Co. Ltd.

13th Floor, No. 128 Sec. 6, Chengde Road

112, Taipei

+

http://www.oep.com.tw
address Orient EuroPharma Co., Ltd.(4120)

Sector

Consumer Non-Cyclicals
Food & Beverages
Food & Tobacco
Food Processing
Special Foods & Wellbeing Products

Sales per Business

Sales per region

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
ORIENT EUROPHARMA CO., LTD. Stock Orient EuroPharma Co., Ltd.
+8.48% 112M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+8.20% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+1.64% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.20% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-8.10% 3.67B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-14.57% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.27% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-18.90% 836M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.45% 802M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 4120 Stock
  4. Company Orient EuroPharma Co., Ltd.